Akèy › Kansè renn › Kalifòni
Etid klinik pou Kansè renn nan Kalifòni
19 etid pou Kansè renn ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- San Diego9 etid
- Los Angeles7 etid
- Baldwin Park6 etid
- Mountain View6 etid
- San Francisco4 etid
- Orange4 etid
- Irvine3 etid
- Sacramento3 etid
Tèks ofisyèl etid la (Anglè)
Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- ak 10 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of California San Diego Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- University of California Irvine, Orange
- Stanford, Palo Alto
- University of California San Francisco, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05287945Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07011719Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04981119Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- City of Hope Investigational Drug Services (IDS), Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- ak 13 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, San Diego
- Research Site, Santa Monica
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05536141Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Los Angeles Site, Duarte
- NEO-811 San Diego Site, San Diego
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Duarte
- Xencor Investigative Site, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05433142Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- University of Southern California, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06026410A Study of VET3-TGI in Patients With Solid Tumors
- USC/Norris Comprehensive Cancer Center, Los Angeles
- UC Irvine Health, Orange
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 7, 2026 · NCT0644481564Cu-GRIP B in Patients With Advanced Malignancies
- University of California, San Francisco, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT05888532cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
- VA Palo Alto Healthcare System, Palo Alto
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 26, 2025 · NCT07303725SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- UCSD Moores Cancer Center, La Jolla
- UCLA Medical Center, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT06682793APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 27, 2025 · NCT03175224International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
- Institute of Urology, University of Southern California., Los Angeles
- University of California San Diego, Moores Cancer Center, San Diego
- Stanford University, Stanford
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2022 · NCT05363657Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.